131 related articles for article (PubMed ID: 9816281)
1. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases.
Younes M; Lechago LV; Lechago J
Clin Cancer Res; 1996 Jul; 2(7):1151-4. PubMed ID: 9816281
[TBL] [Abstract][Full Text] [Related]
2. Human erythrocyte glucose transporter (Glut1) is immunohistochemically detected as a late event during malignant progression in Barrett's metaplasia.
Younes M; Ertan A; Lechago LV; Somoano J; Lechago J
Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):303-5. PubMed ID: 9149888
[TBL] [Abstract][Full Text] [Related]
3. Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival.
Younes M; Juarez D; Lechago LV; Lerner SP
Anticancer Res; 2001; 21(1B):575-8. PubMed ID: 11299807
[TBL] [Abstract][Full Text] [Related]
4. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers.
Younes M; Lechago LV; Somoano JR; Mosharaf M; Lechago J
Cancer Res; 1996 Mar; 56(5):1164-7. PubMed ID: 8640778
[TBL] [Abstract][Full Text] [Related]
5. Expression of the neutral amino acids transporter ASCT1 in esophageal carcinomas.
Younes M; Pathak M; Finnie D; Sifers RN; Liu Y; Schwartz MR
Anticancer Res; 2000; 20(5C):3775-9. PubMed ID: 11268453
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
[TBL] [Abstract][Full Text] [Related]
7. GLUT1 messenger RNA and protein induction relates to the malignant transformation of cervical cancer.
Rudlowski C; Becker AJ; Schroder W; Rath W; Büttner R; Moser M
Am J Clin Pathol; 2003 Nov; 120(5):691-8. PubMed ID: 14608894
[TBL] [Abstract][Full Text] [Related]
8. [Correlations of expressions of Glut1 and HIF-1alpha to cellular proliferation of colorectal adenocarcinoma].
Zhou YL; Deng CS
Ai Zheng; 2005 Jun; 24(6):685-9. PubMed ID: 15946479
[TBL] [Abstract][Full Text] [Related]
9. GLUT1 expression in human breast carcinoma: correlation with known prognostic markers.
Younes M; Brown RW; Mody DR; Fernandez L; Laucirica R
Anticancer Res; 1995; 15(6B):2895-8. PubMed ID: 8669885
[TBL] [Abstract][Full Text] [Related]
10. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid binding protein 6 is overexpressed in colorectal cancer.
Ohmachi T; Inoue H; Mimori K; Tanaka F; Sasaki A; Kanda T; Fujii H; Yanaga K; Mori M
Clin Cancer Res; 2006 Sep; 12(17):5090-5. PubMed ID: 16951225
[TBL] [Abstract][Full Text] [Related]
12. Glucose transporter GLUT1 in colorectal adenocarcinoma cell lines is inversely correlated with tumour cell proliferation.
Hauptmann S; Grünewald V; Molls D; Schmitt WD; Köbel M; Kriese K; Schürmann A
Anticancer Res; 2005; 25(5):3431-6. PubMed ID: 16101160
[TBL] [Abstract][Full Text] [Related]
13. Expression of facilitative glucose transporters in gastric tumors.
Noguchi Y; Marat D; Saito A; Yoshikawa T; Doi C; Fukuzawa K; Tsuburaya A; Satoh S; Ito T
Hepatogastroenterology; 1999; 46(28):2683-9. PubMed ID: 10522065
[TBL] [Abstract][Full Text] [Related]
14. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
[TBL] [Abstract][Full Text] [Related]
15. Significance of GLUT1 expression in adenocarcinoma and adenoma of the ampulla of Vater.
Kim SJ; Lee HW; Kim DC; Rha SH; Hong SH; Jeong JS
Pathol Int; 2008 Apr; 58(4):233-8. PubMed ID: 18324916
[TBL] [Abstract][Full Text] [Related]
16. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
[TBL] [Abstract][Full Text] [Related]
18. [Expression of glucose transporter-1 in endometrial hyperplasia and well-differentiated endometrioid adenocarcinoma].
Liu AJ; Hou N; Chen LZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):398-400. PubMed ID: 12940086
[TBL] [Abstract][Full Text] [Related]
19. Pak-1 expression increases with progression of colorectal carcinomas to metastasis.
Carter JH; Douglass LE; Deddens JA; Colligan BM; Bhatt TR; Pemberton JO; Konicek S; Hom J; Marshall M; Graff JR
Clin Cancer Res; 2004 May; 10(10):3448-56. PubMed ID: 15161701
[TBL] [Abstract][Full Text] [Related]
20. Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression.
Elder DJ; Baker JA; Banu NA; Moorghen M; Paraskeva C
J Pathol; 2002 Dec; 198(4):428-34. PubMed ID: 12434411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
